Interestingly, estradiol, the main physiological endogenous ligand for ER, which had similar effects to 27-HC on cell proliferation, had no effect on p53 activity; this demonstrates that 27-HC may contribute to ER-positive breast cancer progression via different mechanisms compared with known estrogens [55]. The gene discussed is ESR1; the disease is breast carcinoma.